Matthew Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Matthew Wang has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Abigail Leo
Washington and Lee University
1 shared publication - Ashutosh Chilkoti
Department of Biomedical Engineering Duke University Durham North Carolina USA
1 shared publication - Daniel Reker
Duke University
1 shared publication - Lixin Fan
Frederick National Laboratory for Cancer Research
1 shared publication - Sarah Yeon‐Kyoung Kim
Department of Chemistry and Biochemistry Washington and Lee University Lexington Virginia USA
1 shared publication - Taranpreet Kaur
Duke University
1 shared publication
Latest Publications
- Open Access
- 15 October 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Genetically encoded sterol-modification of a synthetic intrinsically disordered protein leads to diverse self-assembly behavior
Post translational modifications (PTMs) of proteins are used by natural systems to expand beyond the 20 canonical amino acids. The variation introduced at the sequence level by PTMs after expression leads to changes in both the structure and function of proteins. PTMs expand the chemical repertoire from which new biomaterials can be constructed. Inspired by the post-translational addition of cholesterol to proteins, we have synthesized five new hybrid lipid-protein biomaterials called Sterol modified polypeptides (STaMPs). These STaMPs consist of an elastin like polypeptide (ELP) conjugated to a sterol, namely coprostanol, epicoprostanol, androstanol, galeterone, or dehydroepiandrosterone. We show that the STaMPs form self-assembled nanostructures such as spherical and cylindrical micelles, and vesicles. Furthermore, the sterols modify the typical LCST behavior of ELPs in a predictable fashion depending on the hydrophobicity of the sterol appended. STaMPs could expand the possibilities for drug delivery by enabling the physical encapsulation of hydrophobic drugs, increasing the solubility and half-life of sterol-based chemotherapeutics, and forming thermosensitive drug depots.
- 15 October 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessGenetically encoded sterol-modification of a synthetic intrinsically disordered protein leads to diverse self-assembly behavior
Post translational modifications (PTMs) of proteins are used by natural systems to expand beyond the 20 canonical amino acids. The variation introduced at the sequence level by PTMs after expression leads to changes in both the structure and function of proteins. PTMs expand the chemical repertoire from which new biomaterials can be constructed. Inspired by the post-translational addition of cholesterol to proteins, we have synthesized five new hybrid lipid-protein biomaterials called Sterol modified polypeptides (STaMPs). These STaMPs consist of an elastin like polypeptide (ELP) conjugated to a sterol, namely coprostanol, epicoprostanol, androstanol, galeterone, or dehydroepiandrosterone. We show that the STaMPs form self-assembled nanostructures such as spherical and cylindrical micelles, and vesicles. Furthermore, the sterols modify the typical LCST behavior of ELPs in a predictable fashion depending on the hydrophobicity of the sterol appended. STaMPs could expand the possibilities for drug delivery by enabling the physical encapsulation of hydrophobic drugs, increasing the solubility and half-life of sterol-based chemotherapeutics, and forming thermosensitive drug depots.